Scarica l'app Stockscreener
3.49
3.56%
0.12
Dopo l'orario di chiusura:
3.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$3.37
Aprire:
$3.4
Volume 24 ore:
2.06M
Relative Volume:
1.42
Capitalizzazione di mercato:
$504.93M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-3.8756
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
+5.76%
1M Prestazione:
+20.76%
6M Prestazione:
+102.91%
1 anno Prestazione:
-57.80%
Intervallo 1D:
$3.39
$3.65
Intervallo di 1 settimana:
$3.14
$3.65
Portata 52W:
$1.665
$8.535
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Confronta MRVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.49 | 467.31M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Neutral |
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Iniziato | Craig Hallum | Buy |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Downgrade | Goldman | Buy → Neutral |
| 2023-01-05 | Downgrade | UBS | Buy → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Stifel | Buy |
| 2020-12-15 | Iniziato | William Blair | Outperform |
| 2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Is Maravai LifeSciences Holdings Inc. stock ready for a breakout2025 Technical Overview & Advanced Technical Analysis Signals - newser.com
What drives Maravai LifeSciences Holdings Inc stock priceInsider Trading Activity & Affordable Investment Portfolio - earlytimes.in
Stock Traders Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
Applying Wyckoff theory to Maravai LifeSciences Holdings Inc. stockEarnings Growth Report & Community Verified Swing Trade Signals - newser.com
Chart overlay techniques for tracking Maravai LifeSciences Holdings Inc.2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Using Ichimoku Cloud for Maravai LifeSciences Holdings Inc. technicalsWeekly Trading Summary & Stock Portfolio Risk Control - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock appeals to dividend investorsJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
How supply shortages influence Maravai LifeSciences Holdings Inc. (MAR) stockMarket Movement Recap & AI Powered Market Entry Strategies - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Weekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com
Tools to assess Maravai LifeSciences Holdings Inc.’s risk profileJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Has Maravai LifeSciences Holdings Inc. formed a bullish divergenceSell Signal & Daily Volume Surge Trade Alerts - newser.com
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Rating of “Hold” from Analysts - Defense World
Will Maravai LifeSciences Holdings Inc. (MAR) stock beat growth indexesPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
Research Frontiers And 2 Other Promising Penny Stocks To Watch - simplywall.st
Custom watchlist performance reports with Maravai LifeSciences Holdings Inc.Trend Reversal & Weekly High Conviction Ideas - newser.com
Detecting support and resistance levels for Maravai LifeSciences Holdings Inc.Portfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
What data driven models say about Maravai LifeSciences Holdings Inc.’s futureWeekly Investment Report & Technical Confirmation Alerts - newser.com
How high can Maravai LifeSciences Holdings Inc. stock goJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Multi asset correlation models including Maravai LifeSciences Holdings Inc. - newser.com
How to interpret RSI for Maravai LifeSciences Holdings Inc. stockGap Down & Weekly Setup with High ROI Potential - newser.com
How hedge fund analytics apply to Maravai LifeSciences Holdings Inc. stockTrend Reversal & Safe Investment Capital Preservation Plans - newser.com
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN
Maravai LifeSciences (NASDAQ:MRVI) Trading 5.9% HigherShould You Buy? - MarketBeat
What’s next for Maravai LifeSciences Holdings Inc. stock priceGap Down & Low Drawdown Momentum Ideas - newser.com
Maravai LifeSciences Holdings Inc.’s volatility index tracking explainedJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Tools to monitor Maravai LifeSciences Holdings Inc. recovery probabilityQuarterly Market Summary & AI Powered Market Entry Strategies - newser.com
Is Maravai LifeSciences Holdings Inc. stock entering bullish territory2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
Using Python tools to backtest Maravai LifeSciences Holdings Inc. strategiesStock Surge & Verified Short-Term Plans - newser.com
Maravai postpones earnings release, delays annual report - MSN
Avantor, Inc. Appoints Gregory T. Lucier to Its Board of Directors - MarketScreener
Key resistance and support levels for Maravai LifeSciences Holdings Inc.2025 Risk Factors & Safe Capital Allocation Plans - newser.com
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):